Carr Douglas 4
4 · Century Therapeutics, Inc. · Filed Feb 5, 2026
Research Summary
AI-generated summary of this filing
Century Therapeutics (IPSC) SVP Finance Carr Douglas Sells 323 Shares
What Happened
Carr Douglas, SVP Finance & Operations at Century Therapeutics (IPSC), reported a sale of 323 shares on 2026-02-03. The shares were sold at $1.82 each for a total proceeds of approximately $589. The filing indicates these sales were to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs).
Key Details
- Transaction date: 2026-02-03; filing date: 2026-02-05 (appears timely).
- Sale details: 323 shares sold at $1.82 per share; total ≈ $589.
- Shares owned after transaction: Not specified in the Form 4 filing.
- Footnote: The sale was automatic to cover tax withholding on RSU vesting (not at the insider’s discretion).
- Transaction code: Reported as a sale (S) with tax-withholding footnote.
Context
This was a small, routine sale to cover tax withholding from RSU vesting rather than an open-market decision to reduce exposure. Such automatic withholding sales are common and generally not taken as a directional signal about the insider’s view of the company.
Insider Transaction Report
Form 4
Carr Douglas
SVP Finance & Operations
Transactions
- Sale
Common Stock
[F1]2026-02-03$1.82/sh−323$589→ 514,551 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
Signature
/s/ Douglas Carr|2026-02-05